Work

S876 Etrasimod Demonstrated Consistent Efficacy and Safety as a Monotherapy or With Concomitant Use of Corticosteroids and/or 5-Aminosalicylates: Results From the ELEVATE UC Clinical Program

Year: 2023

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000953144.15497.a8

Authors: Andres J. Yarur, Michael V. Chiorean, Jessica R. Allegretti, Raymond K. Cross, Christina Ha, Martina Goetsch, Christopher J. Rabbat, Aoibhinn McDonnell, Joseph Wu, Naja Fragante, Arcangelo M. Abbatemarco, Julian Panés

Institutions: Cedars-Sinai Medical Center, Swedish Medical Center, Brigham and Women's Hospital, Harvard University, University of Maryland, Baltimore, Mayo Clinic in Arizona, Pfizer (Switzerland), Pfizer (United States), Pfizer (United Kingdom), Hospital Clínic de Barcelona

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387733377

Cites:

Cited by:

Related to: 10